Answers are grounded in this paper and cite their sources.
The belief that adult mammalian heart lacks regenerative potential was challenged by the identification of c-kit positive Cardiac Progenitor Cells (CPCs) in the heart. SCIPIO; a phase I clinical trial; has shown that autologous c-kit positive CPCs improve cardiac function and quality of life when transplanted into ischemic heart disease patients. c-Kit is a type III receptor tyrosine kinase and a common stem cell antigen. Stem Cell Factor (SCF) is the only known ligand for c-kit. Activation of this membrane bound receptor is known to play a crucial role in many physiological processes like hematopoiesis, immune regulation, pigmentation, gametogenesis, intestinal motility, vasculogenesis, lung and brain development. Likewise, aberrant c-kit stimulation results in several pathological conditions, including tumors of the gut, blood, lung, breast, germ cells, melanocytes and mast cells. Several pro-growth, prosurvival signaling pathways like the MAPK, PI-3K and the phospholipase C and D pathways are involved in mediating the downstream effects, following the activation of this receptor. The goal of this article is to provide a comprehensive review of the structure, function, signaling mechanisms of c-kit activation and its role in normal and pathological conditions.
No takes yet. Share an insight, caveat, or question.
Vajravelu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: